Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction
- PMID: 18335026
- PMCID: PMC2258418
- DOI: 10.1371/journal.pone.0001757
Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction
Abstract
Osteopontin (SPP1) is an important bone matrix mediator found to have key roles in inflammation and immunity. SPP1 genetic polymorphisms and increased osteopontin protein levels have been reported to be associated with SLE in small patient collections. The present study evaluates association between SPP1 polymorphisms and SLE in a large cohort of 1141 unrelated SLE patients [707 European-American (EA) and 434 African-American (AA)], and 2009 unrelated controls (1309 EA and 700 AA). Population-based case-control association analyses were performed. To control for potential population stratification, admixture adjusted logistic regression, genomic control (GC), structured association (STRAT), and principal components analysis (PCA) were applied. Combined analysis of 2 ethnic groups, showed the minor allele of 2 SNPs (rs1126616T and rs9138C) significantly associated with higher risk of SLE in males (P = 0.0005, OR = 1.73, 95% CI = 1.28-2.33), but not in females. Indeed, significant gene-gender interactions in the 2 SNPs, rs1126772 and rs9138, were detected (P = 0.001 and P = 0.0006, respectively). Further, haplotype analysis identified rs1126616T-rs1126772A-rs9138C which demonstrated significant association with SLE in general (P = 0.02, OR = 1.30, 95%CI 1.08-1.57), especially in males (P = 0.0003, OR = 2.42, 95%CI 1.51-3.89). Subgroup analysis with single SNPs and haplotypes also identified a similar pattern of gender-specific association in AA and EA. GC, STRAT, and PCA results within each group showed consistent associations. Our data suggest SPP1 is associated with SLE, and this association is especially stronger in males. To our knowledge, this report serves as the first association of a specific autosomal gene with human male lupus.
Conflict of interest statement
Figures
References
-
- Nath SK, Kilpatrick J, Harley JB. Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol. 2004;16:794–800. - PubMed
-
- Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet. 2002;32:666–669. - PubMed
-
- Kaufman KM, Kelly JA, Herring BJ, Adler AJ, Glenn SB, et al. Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. Arthritis Rheum. 2006;54:2533–2540. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- AR42460/AR/NIAMS NIH HHS/United States
- RR14467/RR/NCRR NIH HHS/United States
- P30 AR053483/AR/NIAMS NIH HHS/United States
- RR01577/RR/NCRR NIH HHS/United States
- N01 AR012253/AR/NIAMS NIH HHS/United States
- AI063622/AI/NIAID NIH HHS/United States
- M01 RR014467/RR/NCRR NIH HHS/United States
- R01 AI024717/AI/NIAID NIH HHS/United States
- P50 AR048940/AR/NIAMS NIH HHS/United States
- AR048940/AR/NIAMS NIH HHS/United States
- AR049084/AR/NIAMS NIH HHS/United States
- DE15223/DE/NIDCR NIH HHS/United States
- R01 DE015223/DE/NIDCR NIH HHS/United States
- AI31584/AI/NIAID NIH HHS/United States
- P20 RR020143/RR/NCRR NIH HHS/United States
- AR048928/AR/NIAMS NIH HHS/United States
- R01 AI031584/AI/NIAID NIH HHS/United States
- RR020143/RR/NCRR NIH HHS/United States
- AI24717/AI/NIAID NIH HHS/United States
- R03 AR048928/AR/NIAMS NIH HHS/United States
- R37 AI024717/AI/NIAID NIH HHS/United States
- R01 AR042460/AR/NIAMS NIH HHS/United States
- AI053747/AI/NIAID NIH HHS/United States
- R21 AI053747/AI/NIAID NIH HHS/United States
- P01 AR049084/AR/NIAMS NIH HHS/United States
- R01 AI063622/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
